A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats | |
Lu, Yu-Yin; Zhao, Cui-Rong; Wang, Rui-Qi; Li, Wen-Bao; Qu, Xian-Jun | |
刊名 | BIOMEDICINE & PHARMACOTHERAPY
![]() |
2015 | |
卷号 | 69页码:255-259 |
关键词 | HL-40 Diarylurea derivative Kinases activities Binding constants (K-d) Pharmacokinetics Anti-tumor activities |
DOI | 10.1016/j.biopha.2014.11.003 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4788467 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Peoples R China. 2.Shandong Univ, Shandong |
推荐引用方式 GB/T 7714 | Lu, Yu-Yin,Zhao, Cui-Rong,Wang, Rui-Qi,et al. A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats[J]. BIOMEDICINE & PHARMACOTHERAPY,2015,69:255-259. |
APA | Lu, Yu-Yin,Zhao, Cui-Rong,Wang, Rui-Qi,Li, Wen-Bao,&Qu, Xian-Jun.(2015).A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats.BIOMEDICINE & PHARMACOTHERAPY,69,255-259. |
MLA | Lu, Yu-Yin,et al."A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats".BIOMEDICINE & PHARMACOTHERAPY 69(2015):255-259. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论